Management guidelines for uninvestigated and functional dyspepsia in the Asia-Pacific region: First Asian Pacific Working Party on Functional Dyspepsia

J Gastroenterol Hepatol. 1998 Apr;13(4):335-53. doi: 10.1111/j.1440-1746.1998.tb00644.x.


Dyspepsia is most optimally defined as pain or discomfort centred in the upper abdomen. The symptom complex may be caused by peptic ulcer disease, gastro-oesophageal reflux, or gastric cancer but is most often due to functional (or non-ulcer) dyspepsia. While upper endoscopy is the method of choice to determine the underlying cause of dyspepsia, it is expensive. A more pragmatic approach is needed in the Asia Pacific region where health services are limited. A detailed treatment algorithm is given for managing patients presenting with new-onset dyspepsia and documented functional dyspepsia after endoscopy, and evidence to support this approach is reviewed. Prompt endoscopy is recommended for patients with alarm features. In patients without alarm features, treatment for 2-4 weeks with an empirical anti-secretory or prokinetic agent, followed by investigation using non-invasive Helicobacter pylori testing and treatment for patients who do not respond or relapse, is recommended. Trials of management strategies are now needed to establish the efficacy and cost-effectiveness of the approaches recommended.

Publication types

  • Consensus Development Conference
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antiemetics / therapeutic use
  • Asia
  • Cisapride
  • Disease Management
  • Domperidone / therapeutic use
  • Dyspepsia* / diagnosis
  • Dyspepsia* / etiology
  • Dyspepsia* / therapy
  • Endoscopy
  • Gastrointestinal Agents / therapeutic use
  • Helicobacter Infections / drug therapy
  • Histamine H2 Antagonists / therapeutic use
  • Humans
  • Pacific Islands
  • Piperidines / therapeutic use


  • Antiemetics
  • Gastrointestinal Agents
  • Histamine H2 Antagonists
  • Piperidines
  • Domperidone
  • Cisapride